Please find information on keynote and plenary speakers below.
Dr Bawo O. JamesConsultant mental health physician and a certified addiction treatment specialist Plenary 3: A Focus on Treatment and Recovery Case Studies of Treatment Programmes in Latin America/Caribbean and Africa |
||
Dr Jane Marie Ong'oloHead of Social Welfare, Vulnerable Groups and Drug Control, African Union Commission Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Continental Perspective – An Overview of Drug Use in Africa |
||
Dr Reychad AbdoolSenior Independent Consultant, Drug Epidemiology, African Union Commission Plenary 4: Epidemiology and its Role in Drug Demand Reduction Co-chair |
||
Dr Abel BasutuSenior Drug Control Programme Officer, African Union Commission Plenary 1: Setting the Scene for Drug Demand Reduction in Africa African Union Plan of Action on Drug Control and Crime Prevention (2019-2023) |
||
H.E. Amira ElfadilCommissioner for Social Affairs, African Union Commission (AUC) Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Setting the Scene
|
||
Roberto CanayPresident, ISSUP Argentina Plenary 4: Epidemiology and its Role in Drug Demand Reduction Overview of Drug epidemiology in Latin American and the Caribbean
|
||
Dr Maristela MonteiroRegional Advisor on Alcohol and Substance Abuse, Pan-American Health Organization (PAHO) Focus on the African context Plenary 2: Evidence-Based Prevention: Policy and Practice Alcohol Use Prevention (data on alcohol use and environmental prevention initiatives) |
||
Ambassador Adam NammExecutive Secretary, Inter-American Drug Abuse Control Commission (CICAD), Organization of the American States (OAS)
|
||
Professor Isidore ObotDirector, Centre for Research and Information on Substance Abuse, Nigeria Plenary 4: Epidemiology and Its Role in Drug Demand Reduction A Continental Overview of Drug Epidemiology in Africa |
||
William D. CranoOskamp Professor of Social Psychology, Division of Behavioral and Organizational Science, Claremont Graduate University Plenary 2: Evidence-based Prevention: Policy and Practice Media-Based Prevention Programmes
|
||
|
Dr Olubusayo AkinolaProgramme Officer, Drug Demand Reduction, ECOWAS Commission Plenary 4: Epidemiology and Its Role in Drug Demand Reduction Regional Perspectives
|
|
Bill McGlynnSenior Advisor, Office of Global Policy and Programs, Drug Demand Reduction, INL, U.S. Department of State Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Global Initiatives by the Bureau of International Narcotics and Law Enforcement Affairs, US State Department |
||
Jeff LeeSenior Consultant, ISSUP Global Plenary 2: Evidence-based Prevention: Policy and Practice What Constitutes Evidence-Based Prevention? |
||
George MurimiTraining Coordinator for Africa, Colombo Plan DAP Plenary 3: A Focus on Treatment and Recovery Best Practices in Treatment and UTC training in Africa |
||
David BayeverAssessor, Examiner and Researcher for the SAPharmacy Council Plenary 2: Evidence-based Prevention: Policy and Practice Plenary Chair |
||
Giovanna CampelloChief, Prevention, Treatment & Rehabilitation Section, UNODC Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Global Perspective – A Global Overview of Drug Use Plenary 2: Evidence-based Prevention: Policy and Practice Prevention Standards |
||
Nazarius TumwesigyeAssociate Professor and Head of Department, Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Uganda Plenary 2: Evidence-based Prevention: Policy and Practice Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives) |
||
Anja BusseProgramme Officer, Prevention, Treatment and Rehabilitation Section, UNODC Plenary 3: A Focus on Treatment and Recovery Treatment Standards |
||
Enrico BisognoChief, Data Development and Dissemination Unit, UNODC Plenary 4: Epidemiology and Its Role in Drug Demand Reduction Synchronising Global Drug Epidemiology Data Collection |
||
Marya HynesChief, Inter-American Observatory on Drugs, CICAD Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Regional Perspective – Latin America and the Caribbean |
||
Pernell ClarkeResearch Specialist, Inter-American Observatory on Drugs, CICAD - Caribbean Plenary 4: Epidemiology and Its Role in Drug Demand Reduction Overview of Drug Epidemiology in Latin America & Caribbean |
||
René Adriana AdamsProgramme Manager, Substance Abuse Prevention and Drug Control Rehabilitation Division, Social Welfare Services Directorate, Ministry of Health and Social Services, Namibia Plenary 2: Evidence-based Prevention: Policy and Practice Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives) |
||
Becky VaughnDirector, Global Centre for Credentialing and Certification (GCCC), Colombo Plan DAP Plenary 3: A Focus on Treatment and Recovery Credentialing and Certification |
||
Chloé CarpentierChief, Drug Research Section, Research Branch, UNODC Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Global Perspective – A Global Overview of Drug Use Plenary 4: Epidemiology and Its Role in Drug Demand Reduction Synchronising Global Drug Epidemiology Data Collection |
||
Brownyn MyersDeputy Director, Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council Plenary 3: A Focus on Treatment and Recovery Service Quality Measurements in Treatment Facilities |
||
Bruno BuiForeign Affairs Officer, Office of Global Policy and Programs, Drug Demand Reduction, INL, U.S. Department of State Plenary 1: Setting the Scene for Drug Demand Reduction in Africa Global Initiatives by the Bureau of International Narcotics and Law Enforcement Affairs, US State Department |
||
Yuri CutipéExecutive Director of Mental Health, Ministry of Health, Peru Plenary 3: A Focus on Treatment and Recovery Case Studies of Treatment Programmes in Latin America/Caribbean and Africa |
||
Neo MorojeleProfessor and Acting HOD, Department of Psychology, University of Johannesburg, South Africa Plenary 2: Evidence-based Prevention: Policy and Practice Alcohol Use Prevention (data on alcohol use, environmental prevention initiatives) |
||
Deputy Minister, Republic of South Africa Department of Social Development (DSD) Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction Plenary Chair |
||
Chairman, Defence and Interior Committee, Parliament of Ghana Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction Role of the Legislator in Drug Demand Reduction |
||
Senator Mattie HunterIllinois State Senator, USA Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction Role of the Legislator in Drug Demand Reduction |
||
Senator Héctor Yépez MartínezPresident of the Commission of Autonomous Governments, Decentralization, Competences and Territorial Development of the Assembly Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction Role of the Legislator in Drug Demand Reduction |
||
Dr Nadine HarkerResearch Scientist, South African Medical Research Council, SENDU/SACENDU Plenary 4: Epidemiology and Its Role in Drug Demand Reduction Regional Perspective |
||
Jennifer Akinyi OrwaProfessor at the Centre for Traditional Medicine and Drugs Research, Kenya Plenary 5: Role of Legislators and Traditional health Practitioners in Drug Demand Reduction Role of Traditional Health Practitioners and Leaders in Drug Demand Reduction (Roundtable Discussion) |
||
Dr Goodman Sibeko
|
||
Dr Pelmos Mashabela
|
||